Novartis AG (ADR) news

   Watch this stock
Showing stories 21 - 30 of about 62   

Articles published

NVS 73.12 0.00 (0.00%)
price chart
Nifty slightly lower; Sun Pharma extends gains to 8%
The company also approved raising up to USD 400 million via FCCB, GDR and ADR. 11:50am The Indian rupee depreciated by 28 paise to 56.24 per dollar, lowest level since July 25, 2012.
Related articles »  
Dow at new high; will Nifty sustain above 6000 today?
Adani Enterprises promoters will sell 1.60 crore shares while Novartis India promoter may sell up to 4.5 lakh shares. Saint-Gobain ... In other fund raising plans, Aban Offshore approved raising upto USD 400 million via FCCB, GDR and ADR. The company ...
Related articles »  
Eisai Announces Launch of Antiepileptic Agent Inovelon(R) Tablets 100 mg, 200 ...
Eisai acquired the exclusive worldwide rights from Novartis Pharma AG in February 2004 to develop, manufacture and market rufinamide and currently markets the agent in more than 20 countries, including in Europe, the United States and Canada.
Related articles »  
Swatch Board Of Directors Re-elected Amid Questions Of Independence
In February, shareholders at Novartis AG (>> Novartis AG), the Swiss pharmaceutical giant, criticized a proposed 72 million-Swiss-franc package to outgoing chairman Daniel Vasella.
Related articles »  
Investment Analysts' Ratings Reiterations for May, 28th (AAP, ABBV, ABT, ACS ...
Advance Auto Parts (NYSE: AAP) had its buy rating reaffirmed by analysts at UBS AG. AbbVie (NASDAQ: ABBV) had its buy rating reissued ... Novartis and Abbott are now our Top European and US picks respectively.� Abbott Laboratories (NYSE: ABT) had its ...
Related articles »